ES
Estrella Immunopharma, Inc. Warrant (ESLAW)
NASDAQ·Healthcare·Biotechnology
$0.06
—
Mkt Cap $3.19M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$236.90
Range $160.68 – $278.10
Implied Upside
+370056.2%
Consensus $236.90 vs current $0.06